| Rapamycin |
|
|
|
99.94% |
| (+)-Usnic acid |
|
|
|
99.64% |
| (2S,6S)-Hydroxynorketamine hydrochloride |
|
|
|
99.30% |
| (32-Carbonyl)-RMC-5552 |
|
|
|
95.41% |
| (Rac)-LRK-4189 |
|
|
|
96.68% |
| (rac)-Monepantel |
|
|
|
99.87% |
| (S)-2-Amino-4,4,4-trifluorobutanoic acid |
|
|
|
|
| (S)-2-Amino-5,5,5-trifluoropentanoic acid |
|
|
|
|
| 1,3,5-Tricaffeoylquinic acid |
|
|
|
|
| 1-Acetyl-DHAP |
|
|
|
|
| 1-O-Hexadecyl-2-O-acetyl-sn-glycerol |
|
|
|
|
| Phenformin |
|
|
|
98.02% |
| 10-Hydroxy-2-decenoic acid |
|
|
|
99.93% |
| 19-epi-Scholaricine |
|
|
|
99.14% |
| 2,6-Dihydroxyacetophenone |
|
|
|
99.85% |
| 2,6-Dimethoxy-1,4-benzoquinone |
|
|
|
98.72% |
| D-α-Hydroxyglutaric acid |
|
|
|
98.0% |
| 22-(4′-py)-JA |
|
|
|
|
| 25(R,S)-Ruscogenin |
|
|
|
99.83% |
| 2DII |
|
|
|
98.92% |
| 3BDO |
|
|
|
99.93% |
| 3HOI-BA-01 |
|
|
|
|
| 4,4'-Sulfonyldiphenol-d8 |
|
|
|
99.21% |
| 4-FPBUA |
|
|
|
|
| 4-Methyl-2-oxopentanoic acid |
|
|
|
98.49% |
| 4-O-Methyl-ascochlorin |
|
|
|
|
| 4-TCPA |
|
|
|
|
| 4-Vinylcyclohexene dioxide |
|
|
|
98.57% |
| 5-HT6 inverse agonist 1 |
|
|
|
|
| 6-Methoxydihydrosanguinarine |
|
|
|
99.88% |
| 6-Methoxydihydrosanguinarine hydrochloride |
|
|
|
|
| 8-Gingerol |
|
|
|
99.82% |
| 8-Aminoadenosine |
|
|
|
99.05% |
| Acesulfame |
|
|
|
|
| AD1058 |
|
|
|
98.04% |
| AGF347 |
|
|
|
|
| AGPAT4-IN-1 |
|
|
|
99.04% |
| AJ2-30 |
|
|
|
99.72% |
| AKT-IN-24 |
|
|
|
|
| Akt/mTOR-IN-1 |
|
|
|
|
| ALK-IN-26 |
|
|
|
99.87% |
| ALK-IN-31 |
|
|
|
|
| AMPK/mTOR modulator-1 |
|
|
|
|
| Anti-CD160 Antibody (MAT 302) |
|
|
|
|
| Anti-inflammatory agent 107 |
|
|
|
|
| Anti-Mouse E-Cadherin/CD324 Antibody (DECMA-1) |
|
|
|
|
| Anticancer agent 271 |
|
|
|
|
| Antifungal agent 106 |
|
|
|
|
| Antiproliferative agent-57 |
|
|
|
|
| Antitumor agent-122 |
|
|
|
|
| Apitolisib |
|
|
|
99.29% |
| AR420626 |
|
|
|
98.40% |
| ARI-1 |
|
|
|
99.16% |
| Aschantin |
|
|
|
|
| ASCT2-IN-1 |
|
|
|
98.21% |
| ASCT2-IN-2 |
|
|
|
99.10% |
| ATM Inhibitor-3 |
|
|
|
|
| ATM Inhibitor-4 |
|
|
|
|
| ATR-IN-20 |
|
|
|
|
| Auriculasin |
|
|
|
98.54% |
| Autophagy inducer 7 |
|
|
|
99.45% |
| AV457 |
|
|
|
|
| Avicin D |
|
|
|
|
| AZD-8055 |
|
|
|
99.60% |
| AZD3147 |
|
|
|
99.93% |
| BGT226 |
|
|
|
99.85% |
| BGT226 maleate |
|
|
|
99.92% |
| BIEGi-1 |
|
|
|
|
| Bimiralisib |
|
|
|
98.62% |
| Bisphenol C |
|
|
|
98.0% |
| BrAC-GGFG-Aminal-PI3K/mTOR-IN-21 |
|
|
|
|
| C-Reactive Protein (CRP) (174-185) |
|
|
|
99.88% |
| C-VGB3 |
|
|
|
|
| CAII-IN-12 |
|
|
|
|
| CAII/VII-IN-1 |
|
|
|
|
| Calebin A |
|
|
|
98.0% |
| Camonsertib |
|
|
|
99.99% |
| Cannflavin B |
|
|
|
98.14% |
| Carbonic anhydrase inhibitor 32 |
|
|
|
|
| Cbz-B3A |
|
|
|
98.63% |
| CC-11 |
|
|
|
|
| CC-115 |
|
|
|
99.10% |
| CC-115 hydrochloride |
|
|
|
98.01% |
| CC-M-1 |
|
|
|
|
| CC214-1 |
|
|
|
98.49% |
| CC214-2 |
|
|
|
98.41% |
| Ceramide (Egg) |
|
|
|
99% |
| Chromeceptin |
|
|
|
99.80% |
| CIDD 0067106 |
|
|
|
|
| COH-17 |
|
|
|
|
| COH-19 |
|
|
|
|
| Coronarin A |
|
|
|
≥98.0% |
| CRI9 |
|
|
|
|
| Cryptolepine |
|
|
|
|
| CZ415 |
|
|
|
98.39% |
| CZ830 |
|
|
|
|
| D-87503 |
|
|
|
|
| D-Glucose 6-phosphate sodium |
|
|
|
98.0% |
| D-Glucose 6-phosphate-13C |
|
|
|
|
| D-GsMTx4 |
|
|
|
99.44% |
| D-GsMTx4 TFA |
|
|
|
99.89% |
| D-α-Hydroxyglutaric acid-13C5 (disodium) |
|
|
|
98.87% |
| D-α-Hydroxyglutaric acid disodium |
|
|
|
98.0% |
| D-Glucose 6-phosphate |
|
|
|
99.90% |
| D-Glucose 6-Phosphate-13C6 (disodium xhydrate) |
|
|
|
99.6% |
| D-Glucose 6-phosphate dipotassium |
|
|
|
|
| Dactolisib |
|
|
|
99.94% |
| Dactolisib hydrochloride |
|
|
|
99.41% |
| Dactolisib Tosylate |
|
|
|
99.87% |
| Dammarenediol II |
|
|
|
99.81% |
| Darlifarnib |
|
|
|
|
| Dehydrovomifoliol |
|
|
|
98.88% |
| Deltafluorine |
|
|
|
|
| DEPTOR-IN-1 |
|
|
|
98.13% |
| Desmethyl-VS-5584 |
|
|
|
|
| Desmethyl-VS-5584 hydrochloride |
|
|
|
98.63% |
| DFX117 |
|
|
|
|
| DHW-221 |
|
|
|
|
| Dihydroevocarpine |
|
|
|
99.62% |
| Dioctanoylphosphatidic acid sodium |
|
|
|
|
| Diphenyl disulfide |
|
|
|
99.96% |
| DQ661 |
|
|
|
|
| DS-7423 |
|
|
|
99.83% |
| eALM1137 |
|
|
|
|
| eCF309 |
|
|
|
98.2% |
| EGFR WT/T790M-IN-4 |
|
|
|
|
| EGFR-IN-192 |
|
|
|
|
| Eriocalyxin B |
|
|
|
99.93% |
| ETP-45658 |
|
|
|
98.97% |
| ETP-46464 |
|
|
|
99.54% |
| Everolimus-13C2,d4 |
|
|
|
|
| FBPase-IN-6 |
|
|
|
|
| FD2024 |
|
|
|
|
| FD274 |
|
|
|
99.45% |
| FDW028 |
|
|
|
99.41% |
| FGF7p |
|
|
|
99.34% |
| FT-1518 |
|
|
|
98.62% |
| FT-1518 (Standard) |
|
|
|
|
| FTI-277 |
|
|
|
|
| FTI-277 TFA |
|
|
|
|
| Ganglioside GT1b (bovine) ammonium |
|
|
|
98% |
| Ganglioside GT1b (porcine) ammonium |
|
|
|
98% |
| GDC-0349 |
|
|
|
99.10% |
| Gedatolisib |
|
|
|
99.89% |
| Gedatolisib-d6 |
|
|
|
|
| Gedatolisib-d8 |
|
|
|
|
| GNE-317 |
|
|
|
98.76% |
| GNE-477 |
|
|
|
98.75% |
| GNE-490 |
|
|
|
96.79% |
| GNE-493 |
|
|
|
99.81% |
| GNE-493 (Standard) |
|
|
|
|
| GNE-555 |
|
|
|
|
| GP262 |
|
|
|
98.43% |
| GSK1059615 |
|
|
|
98.81% |
| GSK3β/mTOR modulator 1 |
|
|
|
|
| Gymnemic acid I |
|
|
|
98.59% |
| HBF-0079 |
|
|
|
|
| HBS-101 |
|
|
|
99.59% |
| HDAC-IN-43 |
|
|
|
|
| HDACs/mTOR Inhibitor 1 |
|
|
|
98.10% |
| HN2210 |
|
|
|
|
| hSMG-1 inhibitor 11e |
|
|
|
99.94% |
| hSMG-1 inhibitor 11j |
|
|
|
99.82% |
| HSP90/mTOR-IN-1 |
|
|
|
|
| HTH-01-091 |
|
|
|
99.81% |
| HTH-01-091 TFA |
|
|
|
98.01% |
| Hydroxycitric acid |
|
|
|
99.31% |
| HYS-072 |
|
|
|
|
| HZX-02-059 |
|
|
|
99.40% |
| IBL-302 |
|
|
|
95.49% |
| ICSN3250 |
|
|
|
|
| ICSN3250 hydrochloride |
|
|
|
|
| Ifupinostat |
|
|
|
99.30% |
| Isocryptotanshinone |
|
|
|
98% |
| Itacnosertib |
|
|
|
99.06% |
| Itacnosertib hydrochloride |
|
|
|
99.43% |
| JM1-24-3 |
|
|
|
|
| JR-AB2-011 |
|
|
|
98.15% |
| K882 |
|
|
|
|
| KIM-161 |
|
|
|
|
| KRAS IN-44 |
|
|
|
|
| KRASG12C IN-16 |
|
|
|
|
| KTC1101 |
|
|
|
98.09% |
| KU-0060648 |
|
|
|
99.87% |
| KU-0063794 |
|
|
|
99.67% |
| Kushenol Z |
|
|
|
|
| L 741742 |
|
|
|
99.28% |
| L 741742 hydrochloride |
|
|
|
|
| L-Borneol 7-O-[β-D-apiofuranosyl-(1→6)]-β-D-glucopyranoside |
|
|
|
99.97% |
| L-Glutamine |
|
|
|
|
| L-Leucine |
|
|
|
98.0% |
| L-Leucine-2-13C |
|
|
|
98% |
| L-Leucine-1-13C,15N |
|
|
|
99.93% |
| L-Leucine-13C |
|
|
|
99.90% |
| L-Leucine-15N |
|
|
|
98.0% |
| L-Leucine-18O2 |
|
|
|
98% |
| L-Leucine-2-13C,15N |
|
|
|
98.0% |
| L-Leucine-d |
|
|
|
|
| L-Leucine-d10 |
|
|
|
99.0% |
| L-Leucine-d2 |
|
|
|
99.81% |
| L-Leucine-d7 |
|
|
|
99.7% |
| L-Leucine-13C6 |
|
|
|
99.64% |
| L-Leucine-13C6,15N |
|
|
|
99.90% |
| L-Leucine-15N,d10 |
|
|
|
|
| L-Leucine-d3 |
|
|
|
99.98% |
| L-Proline |
|
|
|
98.0% |
| L-Proline-d4 |
|
|
|
|
| L-Glutamine-1-13C |
|
|
|
98.0% |
| L-Glutamine-15N |
|
|
|
99.6% |
| L-Glutamine-15N-1 |
|
|
|
98.0% |
| L-Glutamine-15N2 |
|
|
|
99.95% |
| L-Glutamine-15N2,d5 |
|
|
|
|
| L-Glutamine-5-13C |
|
|
|
98.0% |
| L-Glutamine-d5 |
|
|
|
99.79% |
| L-Glutamine-13C5 |
|
|
|
99.93% |
| L-Glutamine-13C5,15N2 |
|
|
|
98.0% |
| L-Glutamine-13C5,15N2,d5 |
|
|
|
99.95% |
| LASSBio-2337 |
|
|
|
|
| Levomilnacipran |
|
|
|
|
| Levomilnacipran-d10 hydrochloride |
|
|
|
|
| LGB321 |
|
|
|
|
| LGB321 monohydrochloride |
|
|
|
|
| Licoflavanone |
|
|
|
|
| LP-65 |
|
|
|
|
| LRK-4189 |
|
|
|
|
| Lupenone |
|
|
|
99.74% |
| M-1111 |
|
|
|
|
| Maackiain |
|
|
|
99.83% |
| Mastoparan 17 |
|
|
|
98.09% |
| MCX 28 |
|
|
|
|
| Mefluleucine |
|
|
|
98.0% |
| Mefluleucine hydrochloride |
|
|
|
98.0% |
| Metformin (glycinate) |
|
|
|
|
| Metformin-13C2 (hydrochloride) |
|
|
|
|
| Methionyl-methionine |
|
|
|
|
| Methyl Eugenol |
|
|
|
99.79% |
| Metyrapone Tartrate |
|
|
|
|
| MHY-1685 |
|
|
|
99.84% |
| MHY1485 |
|
|
|
99.93% |
| Mitochondrial complex I-IN-1 |
|
|
|
|
| MK-2206 |
|
|
|
99.72% |
| MK-2206 dihydrochloride |
|
|
|
99.94% |
| MK-2206 free base |
|
|
|
|
| MKC-1 |
|
|
|
99.78% |
| Molephantin |
|
|
|
|
| Momordicine I |
|
|
|
97.0% |
| Monascuspiloin |
|
|
|
95% |
| Monepantel |
|
|
|
99.98% |
| MT 63-78 |
|
|
|
98.11% |
| MT-125 |
|
|
|
98.73% |
| MT-125 free base |
|
|
|
98.67% |
| MT-44 |
|
|
|
|
| MTI-31 |
|
|
|
99.98% |
| MTOR Human Pre-designed siRNA Set A |
|
|
|
|
| mTOR inhibitor WYE-28 |
|
|
|
99.25% |
| mTOR inhibitor-1 |
|
|
|
98.82% |
| mTOR inhibitor-10 |
|
|
|
|
| mTOR inhibitor-11 |
|
|
|
|
| mTOR inhibitor-12 |
|
|
|
|
| mTOR inhibitor-13 |
|
|
|
|
| mTOR inhibitor-14 |
|
|
|
|
| mTOR inhibitor-16 |
|
|
|
|
| mTOR inhibitor-17 |
|
|
|
|
| mTOR inhibitor-18 |
|
|
|
|
| mTOR inhibitor-2 |
|
|
|
|
| mTOR inhibitor-23 |
|
|
|
|
| mTOR inhibitor-24 |
|
|
|
|
| mTOR inhibitor-26 |
|
|
|
|
| mTOR inhibitor-27 |
|
|
|
|
| mTOR inhibitor-28 |
|
|
|
|
| mTOR inhibitor-3 |
|
|
|
99.79% |
| mTOR inhibitor-8 |
|
|
|
98.14% |
| Mtor Mouse Pre-designed siRNA Set A |
|
|
|
|
| Mtor Rat Pre-designed siRNA Set A |
|
|
|
|
| mTOR-IN-29 |
|
|
|
|
| mTOR/GLS1-IN-1 |
|
|
|
|
| mTOR/HDAC-IN-1 |
|
|
|
|
| mTOR/HDAC6-IN-1 |
|
|
|
|
| mTOR/STAT3-IN-1 |
|
|
|
|
| mTORC1-IN-2 |
|
|
|
|
| mTORC1-IN-3 |
|
|
|
|
| C24-Ceramide |
|
|
|
99.92% |
| N-Hydroxyphthalimide |
|
|
|
99.63% |
| N1,N11-Diethylnorspermine tetrahydrochloride |
|
|
|
99.82% |
| NEO214 |
|
|
|
98.0% |
| Nic-15 |
|
|
|
|
| NMac1 |
|
|
|
|
| NPS 2390 |
|
|
|
99.90% |
| NS1-IN-1 |
|
|
|
|
| NSC126405 |
|
|
|
99.20% |
| NSC47924 |
|
|
|
95.0% |
| NSC647889 |
|
|
|
99.28% |
| NSC781406 |
|
|
|
99.97% |
| Nur77 modulator 3 |
|
|
|
99.01% |
| NV-5440 |
|
|
|
|
| NVP-BBD130 |
|
|
|
|
| Omipalisib |
|
|
|
99.94% |
| Onatasertib |
|
|
|
99.47% |
| OSI-027 |
|
|
|
99.95% |
| OSU-03013 |
|
|
|
|
| OSU-53 |
|
|
|
|
| Ovalitenone |
|
|
|
|
| OXA-01 |
|
|
|
|
| P-2281 |
|
|
|
99.81% |
| Palomid 529 |
|
|
|
99.37% |
| Panulisib |
|
|
|
|
| Paxalisib |
|
|
|
99.51% |
| PD-1/PD-L1-IN-62 |
|
|
|
|
| PD-M6 |
|
|
|
98.17% |
| Pertuzumab-LD3 |
|
|
|
|
| PF-04455242 |
|
|
|
|
| PF-04691502 |
|
|
|
99.33% |
| PF-04979064 |
|
|
|
99.93% |
| PF-05139962 |
|
|
|
|
| PF-06465603 |
|
|
|
|
| PF-4455242 hydrochloride |
|
|
|
99.01% |
| Physalin A |
|
|
|
99.63% |
| PI-103 |
|
|
|
99.82% |
| PI-103 Hydrochloride |
|
|
|
98.06% |
| PI-540 |
|
|
|
|
| PI3K-IN-22 |
|
|
|
99.50% |
| PI3K-IN-37 |
|
|
|
99.0% |
| PI3K/Akt/mTOR-IN-2 |
|
|
|
99.93% |
| PI3K/Akt/mTOR-IN-3 |
|
|
|
|
| PI3K/Akt/mTOR-IN-4 |
|
|
|
|
| PI3K/Akt/mTOR-IN-5 |
|
|
|
|
| PI3K/Akt/mTOR-IN-6 |
|
|
|
|
| PI3K/Akt/mTOR-IN-7 |
|
|
|
|
| PI3K/HDAC-IN-4 |
|
|
|
|
| PI3K/mTOR Inhibitor-1 |
|
|
|
|
| PI3K/mTOR Inhibitor-11 |
|
|
|
99.65% |
| PI3K/mTOR Inhibitor-12 |
|
|
|
|
| PI3K/mTOR Inhibitor-13 |
|
|
|
|
| PI3K/mTOR Inhibitor-13 sodium |
|
|
|
98.11% |
| PI3K/mTOR Inhibitor-14 |
|
|
|
|
| PI3K/mTOR Inhibitor-17 |
|
|
|
|
| PI3K/mTOR Inhibitor-2 |
|
|
|
99.10% |
| PI3K/mTOR Inhibitor-3 |
|
|
|
|
| PI3K/mTOR Inhibitor-4 |
|
|
|
97.04% |
| PI3K/mTOR Inhibitor-5 |
|
|
|
|
| PI3K/mTOR Inhibitor-6 |
|
|
|
|
| PI3K/mTOR Inhibitor-7 |
|
|
|
|
| PI3K/mTOR Inhibitor-8 |
|
|
|
|
| PI3K/mTOR Inhibitor-9 |
|
|
|
|
| PI3K/mTOR ligand-1 |
|
|
|
97.28% |
| PI3K/mTOR-IN-17 |
|
|
|
|
| PI3K/mTOR-IN-18 |
|
|
|
|
| PI3K/mTOR-IN-19 |
|
|
|
|
| PI3K/mTOR-IN-20 |
|
|
|
|
| PI3K/mTOR-IN-21 |
|
|
|
|
| PI3K/mTOR-IN-22 |
|
|
|
|
| PI3K/mTOR-IN-23 |
|
|
|
99.0% |
| PI3K/mTOR-IN-23 dihydrochloride |
|
|
|
99.70% |
| PI3Kα-IN-27 |
|
|
|
|
| PI3Kα-IN-29 |
|
|
|
|
| PI3Kα-IN-33 |
|
|
|
|
| PI3Kα-IN-5 |
|
|
|
|
| PI3Kα/mTOR-IN-1 |
|
|
|
99.30% |
| PI5P4Kγ-IN-1 |
|
|
|
98.82% |
| PKI-179 |
|
|
|
98.0% |
| PKI-179 hydrochloride |
|
|
|
99.66% |
| PKI-402 |
|
|
|
99.17% |
| PKi-402 (Standard) |
|
|
|
|
| PLS-123 |
|
|
|
|
| PM54-1 |
|
|
|
|
| Pongamol |
|
|
|
99.81% |
| PP121 |
|
|
|
99.51% |
| PP30 |
|
|
|
98.01% |
| PP487 |
|
|
|
|
| PPM-18 |
|
|
|
99.17% |
| PQR530 |
|
|
|
99.85% |
| PQR530 (Standard) |
|
|
|
|
| PQR620 |
|
|
|
98.01% |
| PQR626 |
|
|
|
99.96% |
| Procyanidin C2 |
|
|
|
|
| PROTAC Sirt2 Degrader-2 |
|
|
|
|
| PT-88 |
|
|
|
|
| PUC-10 |
|
|
|
|
| PWT-33597 |
|
|
|
|
| PWT-33597 free base |
|
|
|
|
| QL-IX-55 |
|
|
|
|
| RapaLink-1 |
|
|
|
99.65% |
| Rapamycin-13C,d3-1 |
|
|
|
|
| Rapastinel acetate |
|
|
|
|
| Rapastinel Trifluoroacetate |
|
|
|
98.0% |
| Rheb inhibitor NR1 |
|
|
|
99.26% |
| Rhodiolin |
|
|
|
98% |
| Ridaforolimus |
|
|
|
99.75% |
| RMC-4529 |
|
|
|
|
| RMC-4627 |
|
|
|
98.41% |
| RMC-4745 |
|
|
|
|
| RMC-4998 |
|
|
|
99.31% |
| RMC-4998 formic |
|
|
|
|
| RMC-4998 TFA |
|
|
|
99.02% |
| RMC-5552 |
|
|
|
99.94% |
| RMC-6272 |
|
|
|
95.05% |
| ROR1-IN-3 |
|
|
|
|
| Royleanone |
|
|
|
|
| Samotolisib |
|
|
|
98.85% |
| Sarmentosin |
|
|
|
97.0% |
| Schisantherin B |
|
|
|
99.75% |
| Scoulerine hydrochloride |
|
|
|
|
| SI-W052 |
|
|
|
98.0% |
| Sialorphin |
|
|
|
|
| Sialorphin TFA |
|
|
|
|
| Simufilam |
|
|
|
99.78% |
| Simufilam dihydrochloride |
|
|
|
|
| Simufilam hydrochloride |
|
|
|
99.85% |
| Sirolimus isomer C |
|
|
|
|
| SIRT6-IN-3 |
|
|
|
98.19% |
| SKI-349 |
|
|
|
99.48% |
| SKLB-D18 |
|
|
|
98.06% |
| SN32976 |
|
|
|
99.49% |
| SPR519 |
|
|
|
|
| SSI-4 |
|
|
|
99.99% |
| Stearamide |
|
|
|
97.0% |
| STF-118804 |
|
|
|
99.72% |
| SU212 |
|
|
|
|
| Sulindac Sulfone-d6 |
|
|
|
|
| T133 |
|
|
|
|
| T7 Peptide |
|
|
|
|
| T7 Peptide TFA |
|
|
|
98.20% |
| Tegafur-gimeracil-oteracil potassium |
|
|
|
99.96% |
| Temsirolimus |
|
|
|
99.51% |
| Theasaponin E1 |
|
|
|
99.08% |
| Thioether-cyclized helix B peptide, CHBP |
|
|
|
|
| Thioether-cyclized helix B peptide, CHBP TFA |
|
|
|
|
| TMBIM6 antagonist-1 |
|
|
|
98.92% |
| TML-6 |
|
|
|
98.34% |
| TML-6-d3 |
|
|
|
|
| Topo I/II-IN-2 |
|
|
|
|
| Torin 1 |
|
|
|
99.28% |
| Torin 2 |
|
|
|
99.65% |
| Torkinib |
|
|
|
99.03% |
| Toyaburgine |
|
|
|
|
| Tubulin-IN-64 |
|
|
|
|
| Tulrampator |
|
|
|
99.39% |
| VEGFR-2-IN-77 |
|
|
|
|
| Voxtalisib |
|
|
|
99.82% |
| VS-5584 |
|
|
|
98.71% |
| WAY-600 |
|
|
|
99.86% |
| WH23 |
|
|
|
|
| Withangulatin A |
|
|
|
99.76% |
| WJD008 |
|
|
|
|
| WRX606 |
|
|
|
95.65% |
| WYE-132 |
|
|
|
99.90% |
| WYE-23 |
|
|
|
99.24% |
| WYE-354 |
|
|
|
98.03% |
| WYE-687 |
|
|
|
98.05% |
| WYE-687 dihydrochloride |
|
|
|
|
| XL388 |
|
|
|
99.57% |
| Y-27632 |
|
|
|
99.46% |
| Y-27632 hydrochloride hydrate |
|
|
|
99.65% |
| YB-3–17 |
|
|
|
|
| YJ1206 |
|
|
|
97.26% |
| Yuanhuadin |
|
|
|
|
| YVPGP |
|
|
|
|
| YW3-56 hydrochloride |
|
|
|
|
| α-Methyl-DL-tryptophan |
|
|
|
99.99% |
| α-Neoendorphin (porcine) |
|
|
|
|
| α-Solanine |
|
|
|
99.89% |
| Beta-Sitosterol (purity>98%) |
|
|
|
99.74% |
| Notoginsenoside Ft1 |
|
|
|
99.49% |
| Trifolirhizin |
|
|
|
98.37% |
| Ethanolamine-d7 |
|
|
|
98.93% |
| Ethanolamine |
|
|
|
99.98% |
| N1,N11-Diethylnorspermine |
|
|
|
|
| Dihydromyricetin-d4 |
|
|
|
|
| Dihydromyricetin |
|
|
|
99.73% |
| Metformin |
|
|
|
99.96% |
| Metformin-d6 |
|
|
|
98.16% |
| Everolimus |
|
|
|
99.85% |
| Everolimus-d4 |
|
|
|
98.74% |
| Perfluoroundecanoic acid-13C7 |
|
|
|
|
| Perfluoroundecanoic acid |
|
|
|
99.85% |
| Perfluorotetradecanoic acid |
|
|
|
98.0% |
| Ononin |
|
|
|
99.97% |
| Flavokawain C |
|
|
|
99.53% |
| Bicyclol |
|
|
|
99.91% |
| 4,4'-Sulfonyldiphenol |
|
|
|
99.44% |
| Pyraclostrobin-d6 |
|
|
|
99.90% |
| Pyraclostrobin |
|
|
|
99.91% |
| Tioconazole |
|
|
|
99.90% |
| Tetrahydroalstonine |
|
|
|
99.84% |
| Dinutuximab |
|
|
|
≥99.0% |
| Doxepin |
|
|
|
99.66% |
| Cefminox sodium |
|
|
|
99.83% |
| Vistusertib |
|
|
|
99.70% |
| Clemastine fumarate |
|
|
|
99.96% |
| Clemastine-d5 fumarate |
|
|
|
99.79% |
| Arnicolide D |
|
|
|
99.69% |
| Levomilnacipran hydrochloride |
|
|
|
99.95% |
| Levomilnacipran-d5 hydrochloride |
|
|
|
|
| Isoviolanthin |
|
|
|
99.87% |
| Isoacteoside |
|
|
|
99.73% |
| Guaiazulene |
|
|
|
99.08% |
| Manganese chloride |
|
|
|
99.1% |
| Pinoresinol Diglucoside |
|
|
|
99.84% |
| Phlorizin |
|
|
|
99.93% |
| Phlorizin dihydrate |
|
|
|
98.0% |
| Kuwanon G |
|
|
|
99.45% |
| (+)-Medioresinol |
|
|
|
99.13% |
| Phaseoloidin |
|
|
|
99.92% |
| Pomiferin |
|
|
|
98.01% |
| Zinc chloride, for cell culture |
|
|
|
|
| Clemastine |
|
|
|
99.26% |
| Sapanisertib |
|
|
|
99.78% |
| Arenobufagin |
|
|
|
99.82% |
| Macranthoside B |
|
|
|
99.95% |
| Succinylsulfathiazole (Standard) |
|
|
|
95% |
| Succinylsulfathiazole |
|
|
|
99.22% |
| Daphnetin |
|
|
|
99.77% |
| Licoricesaponin G2 |
|
|
|
99.87% |
| Lomitapide mesylate |
|
|
|
99.57% |
| Ajugol |
|
|
|
99.61% |
| Metformin-d6 hydrochloride |
|
|
|
99.98% |
| Metformin hydrochloride |
|
|
|
99.98% |
| Phenformin hydrochloride |
|
|
|
99.64% |
| Phenformin-d5 hydrochloride |
|
|
|
|
| Phellodendrine chloride |
|
|
|
99.68% |
| Raddeanin A |
|
|
|
98.68% |
| Salidroside |
|
|
|
99.88% |
| Rohitukine |
|
|
|
|
| Hydroxycitric acid tripotassium |
|
|
|
98.0% |
| Voacamine |
|
|
|
99.64% |
| Lipoteichoic acid |
|
|
|
|
| Sulindac sulfone |
|
|
|
98.10% |
| Aloe emodin |
|
|
|
98.32% |
| Rubrofusarin gentiobioside |
|
|
|
99.07% |
| Atractyloside potassium salt |
|
|
|
99.93% |
| Sotetsuflavone |
|
|
|
|
| Orcinol glucoside |
|
|
|
98.92% |
| Curzerenone |
|
|
|
98.55% |
| Fusaric acid |
|
|
|
99.94% |
| Jervine hydriodide |
|
|
|
|
| Zederone |
|
|
|
99.61% |
| Coenzyme Q0 |
|
|
|
99.79% |
| Daporinad |
|
|
|
99.91% |
| Daporinad hydrochloride |
|
|
|
|
| Telocinobufagin |
|
|
|
99.50% |
| Polyphyllin I |
|
|
|
99.91% |
| Scoulerine |
|
|
|
99.99% |
| Rotundic acid |
|
|
|
98.41% |
| Arjunolic acid |
|
|
|
98.17% |
| Psicose |
|
|
|
99.90% |
| Cryptochlorogenic acid |
|
|
|
99.23% |
| Rapastinel |
|
|
|
99.78% |
| Rapamycin (GMP Like) |
|
|
|
|
| Rapamycin |
|
|
|
|
| Rapamycin (Standard) |
|
|
|
99% |
| Rapamycin-d3 |
|
|
|
95.92% |
| Rapamycin-13C,d3 |
|
|
|
97.05% |
| Hederacolchiside A1 |
|
|
|
98.0% |
| Typhaneoside |
|
|
|
99.74% |
| Cyclovirobuxine D |
|
|
|
99.70% |
| Phellodendrine |
|
|
|
|
| Veratramine |
|
|
|
99.88% |
| Sinigrin |
|
|
|
99.92% |
| Sinigrin hydrate |
|
|
|
99.92% |
| Bellidifolin |
|
|
|
99.74% |